Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

31 March 2016 : Original article  

Liver Transplantation and Donor Body Mass Index >30: Use or Refuse?

Anne AndertABCDEF, Niklas BeckerBC, Florian UlmerB, Wenzel SchöningB, Marc HeinBC, Alexandra RimekBC, Ulf NeumannA, Maximilian SchmedingADE

DOI: 10.12659/AOT.896101

Ann Transplant 2016; 21:185-193

Abstract

BACKGROUND: Organ shortage is a major problem in liver transplantation. The use of extended criteria donors has become the most important strategy for increasing the donor pool. However, the role of donor body mass index has not yet been thoroughly investigated. The aim of our study was to compare outcomes after liver transplantation in patients who received a liver from a donor with a BMI <30, 30–39, and ≥40, with special regard to the incidence of early allograft dysfunction (EAD) and primary non-function (PNF).

MATERIAL AND METHODS: One hundred and sixty-three patients who underwent liver transplantation at the University Hospital Aachen between June 2010 and January 2014 were included in this analysis. The outcome of liver transplantation was evaluated by the 30-day and 1-year patient and graft survival rates and the incidences of post-reperfusion syndrome (PRS), EAD, and PNF.

RESULTS: The BMI 30–39 group had a higher incidence of EAD than the BMI <30 and BMI ≥40 groups. We observed 5 cases of PNF in the BMI <30 group. The incidence of acute renal failure was significantly higher in the BMI 30–39 and BMI ≥40 groups than in the BMI <30 group. Patient and graft survival did not differ significantly among the 3 groups.

CONCLUSIONS: Based on the findings of this study, grafts from obese donors with a BMI >30 can be safely transplanted. Therefore, the donor pool can be enlarged to include such obese donors without a negative impact on the long-term patient outcome after liver transplantation.

Keywords: Body Mass Index, Donor Selection, Liver Transplantation

Add Comment 0 Comments

In Press

Original article  

Preoperative Evidence-Based Practice for Prevention of Early Postoperative Infections in Patients Receiving...

Ann Transplant In Press; DOI: 10.12659/AOT.943610  

Original article  

Prediction of Renal Graft Function 1 Year After Adult Deceased-Donor Kidney Transplantation Using Variables...

Ann Transplant In Press; DOI: 10.12659/AOT.944603  

Original article  

Impact of Donor-Recipient Relationship on Long-Term Outcomes in Living-Related Donor Kidney Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.945065  

Case report  

Successful Interventional Therapy for Portal Vein Stenosis after Ex Vivo Liver Resection and Autotransplant...

Ann Transplant In Press; DOI: 10.12659/AOT.944851  

Most Viewed Current Articles

05 Apr 2022 : Original article   12,824

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   9,807

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

12 Jan 2022 : Original article   9,234

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

15 Mar 2022 : Case report   7,029

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358